FDA Inspection 1153607 — Oleh Kobziev
The FDA completed an inspection of Oleh Kobziev on September 3, 2021 in Kharkiv. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 3, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Kharkiv (Ukraine)
Additional Details
Clinical Investigator (CI)